Company news
Silo Pharma, Inc. news in 2020
Silo Pharma, Inc.'s news releases, calls and decks from 2020, newest first.
Silo Pharma, Inc. Enhances Scientific Advisory Board with Appointment of Dr. Charles B. Nemeroff of University of Texas at Austin
December 14, 2020
Silo Pharma, Inc. Expands Scientific Advisory Board with Appointment of Dr. Peter Hendricks of University of Alabama at Birmingham
December 6, 2020
Silo Pharma Announces Plans for a Phase 2B Investigator Lead Study Using Psychedelics Psilocybin and Lysergic Acid Diethylamide (“LSD”) to Treat Parkinson’s Disease
December 1, 2020
Silo Pharma, Inc. Expands Scientific Advisory Board with the Appointment of Dr. Joshua Woolley of University of California, San Francisco
November 15, 2020
Silo Pharma, Inc. Announces Filing of Three U.S. Provisional Patent Applications
November 11, 2020
Silo Pharma, Inc. Launches Scientific Advisory Board with Appointment of Dr. Matthew Johnson of John Hopkins University
November 8, 2020
Silo Pharma, Inc. (SILO) Announces Successful Uplisting To the OTCQB Venture Market
October 13, 2020
Silo Pharma, Inc. Enters into Option Agreement with University of Maryland Baltimore for Central Nervous System-Homing Peptides
October 12, 2020
Silo Pharma, Inc. Expands Board with Appointment of Dr. Kevin Muñoz MD; Announces Application to Uplist to OTCQB Market
October 5, 2020